Stock listing
NASDAQ:CV CapsoVision, Inc. Stock
Home listing (NASDAQ) of CapsoVision, Inc.
Follow CapsoVision, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:CV
$6.11 USD -0.71 (-10.4%)
Close on Nov 20, 2026
- Day range
- $6.01 – $6.37 USDNov 20, 2026
- Volume
- 178,651 sharesNov 20, 2026
- Market cap
- $325.1M USDAt the close on Nov 20, 2026 · price × 53.21M shares outstanding
- 52-week range
- $4.50 – $15.37 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $1.11M USDMedian day 119,878 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CV · Home | $6.11 USD | -0.71 (-10.4%) | 178,651 | $6.26 | $6.37 | $6.01 | $6.82 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:CV · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $6.11 | -0.71 | -10.4% | $6.26 | $6.37 | $6.01 | 178,651 | |
| $6.82 | +0.17 | +2.6% | $6.63 | $6.87 | $6.555 | 159,750 | |
| $6.65 | +0.18 | +2.8% | $6.46 | $6.67 | $6.30 | 158,048 | |
| $6.47 | +0.44 | +7.3% | $6.07 | $6.57 | $6.02 | 169,778 | |
| $6.03 | -0.24 | -3.8% | $6.36 | $6.38 | $5.86 | 168,680 | |
| $6.27 | 0.00 | 0.0% | $6.35 | $6.40 | $6.121 | 91,318 | |
| $6.27 | -0.10 | -1.6% | $6.42 | $6.58 | $6.27 | 58,564 | |
| $6.37 | -0.07 | -1.1% | $6.40 | $6.56 | $6.27 | 65,037 | |
| $6.44 | +0.12 | +1.9% | $6.32 | $6.555 | $6.313 | 66,462 | |
| $6.32 | +0.12 | +1.9% | $6.22 | $6.44 | $6.17 | 119,878 | |
| $6.20 | -0.65 | -9.5% | $6.92 | $6.92 | $6.14 | 141,934 | |
| $6.85 | +0.15 | +2.2% | $6.81 | $7.05 | $6.79 | 135,979 | |
| $6.70 | -0.03 | -0.4% | $6.79 | $6.81 | $6.375 | 245,894 | |
| $6.73 | -0.10 | -1.5% | $6.91 | $7.01 | $6.70 | 104,484 | |
| $6.83 | -0.11 | -1.6% | $6.99 | $7.10 | $6.79 | 86,746 | |
| $6.94 | -0.12 | -1.7% | $7.10 | $7.23 | $6.89 | 101,900 | |
| $7.06 | +0.31 | +4.6% | $6.78 | $7.13 | $6.77 | 220,300 | |
| $6.75 | -0.14 | -2.0% | $6.94 | $6.98 | $6.71 | 111,700 | |
| $6.89 | -0.10 | -1.4% | $7.00 | $7.09 | $6.63 | 104,800 | |
| $6.99 | +0.19 | +2.8% | $6.72 | $7.18 | $6.66 | 320,200 | |
| $6.80 | 0.00 | 0.0% | $6.75 | $6.80 | $6.73 | 111,400 | |
| $6.80 | +0.12 | +1.8% | $6.73 | $6.80 | $6.67 | 171,400 | |
| $6.68 | +0.01 | +0.1% | $6.70 | $6.78 | $6.68 | 62,400 | |
| $6.67 | +0.14 | +2.1% | $6.53 | $6.74 | $6.48 | 76,200 | |
| $6.53 | +0.08 | +1.2% | $6.46 | $6.65 | $6.40 | 160,800 | |
| $6.45 | -0.19 | -2.9% | $6.69 | $6.75 | $6.24 | 170,000 | |
| $6.64 | -0.14 | -2.1% | $6.74 | $6.79 | $6.615 | 80,300 | |
| $6.78 | +0.02 | +0.3% | $6.76 | $6.803 | $6.64 | 86,800 | |
| $6.76 | +0.17 | +2.6% | $6.54 | $6.81 | $6.53 | 107,200 | |
| $6.59 | -0.03 | -0.5% | $6.62 | $6.73 | $6.535 | 58,000 | |
| $6.62 | +0.08 | +1.2% | $6.48 | $6.71 | $6.41 | 91,400 | |
| $6.54 | +0.04 | +0.6% | $6.39 | $6.58 | $6.385 | 104,500 | |
| $6.50 | -0.085 | -1.3% | $6.60 | $6.60 | $6.35 | 69,500 | |
| $6.585 | +0.415 | +6.7% | $6.13 | $6.61 | $6.11 | 90,400 | |
| $6.17 | -0.15 | -2.4% | $6.35 | $6.40 | $6.12 | 128,700 | |
| $6.32 | -0.14 | -2.2% | $6.40 | $6.54 | $6.25 | 159,400 | |
| $6.46 | -0.23 | -3.4% | $6.72 | $6.786 | $6.37 | 155,300 | |
| $6.69 | -0.23 | -3.3% | $6.90 | $6.98 | $6.55 | 245,000 | |
| $6.92 | +0.27 | +4.1% | $6.60 | $6.94 | $6.50 | 352,700 | |
| $6.65 | +0.48 | +7.8% | $6.18 | $6.69 | $6.17 | 184,600 | |
| $6.17 | +0.12 | +2.0% | $6.05 | $6.19 | $5.88 | 216,900 | |
| $6.05 | -0.25 | -4.0% | $6.26 | $6.32 | $6.03 | 443,200 | |
| $6.30 | +0.11 | +1.8% | $6.25 | $6.33 | $6.00 | 271,800 | |
| $6.19 | -0.51 | -7.6% | $6.91 | $6.91 | $6.07 | 170,600 | |
| $6.70 | +0.37 | +5.8% | $6.26 | $6.75 | $6.26 | 1,614,300 | |
| $6.33 | +0.34 | +5.7% | $6.04 | $6.42 | $6.01 | 174,700 | |
| $5.99 | -0.39 | -6.1% | $6.40 | $6.64 | $5.98 | 509,000 | |
| $6.38 | -0.13 | -2.0% | $6.50 | $6.74 | $6.35 | 250,500 | |
| $6.51 | -0.09 | -1.4% | $6.60 | $6.85 | $6.50 | 224,600 | |
| $6.60 | +0.08 | +1.2% | $6.54 | $6.895 | $6.505 | 207,100 | |
| $6.52 | +0.15 | +2.4% | $6.29 | $6.70 | $6.29 | 163,600 | |
| $6.37 | +0.01 | +0.2% | $6.30 | $6.68 | $6.24 | 185,300 | |
| $6.36 | +0.37 | +6.2% | $5.99 | $6.99 | $5.99 | 391,400 | |
| $5.99 | +0.02 | +0.3% | $5.93 | $6.09 | $5.92 | 38,500 | |
| $5.97 | +0.04 | +0.7% | $6.01 | $6.01 | $5.83 | 62,700 | |
| $5.93 | +0.06 | +1.0% | $5.88 | $6.05 | $5.88 | 58,600 | |
| $5.87 | +0.03 | +0.5% | $5.80 | $5.97 | $5.785 | 62,200 | |
| $5.84 | -0.09 | -1.5% | $5.95 | $6.13 | $5.81 | 58,500 | |
| $5.93 | -0.13 | -2.1% | $6.13 | $6.284 | $5.93 | 83,000 | |
| $6.06 | +0.24 | +4.1% | $5.80 | $6.115 | $5.75 | 75,100 | |
| $5.82 | -0.03 | -0.5% | $5.88 | $5.92 | $5.77 | 50,400 | |
| $5.85 | +0.02 | +0.3% | $5.89 | $6.00 | $5.785 | 74,517 | |
| $5.83 | -0.19 | -3.2% | $6.05 | $6.18 | $5.82 | 77,082 | |
| $6.02 | +0.11 | +1.9% | $5.95 | $6.14 | $5.86 | 68,700 | |
| $5.91 | -0.21 | -3.4% | $6.12 | $6.255 | $5.895 | 105,200 |
- Ticker
- NASDAQ:CV
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 12, 2026
CapsoVision Reports Third Quarter 2026 Financial Results
Latest earnings call · Nov 12, 2026
CapsoVision (NASDAQ:CV) Q3 2026 Earnings Call
Replay and transcript
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 20 slides
Latest news
CapsoVision Reports Third Quarter 2026 Financial Results
Nov 12, 2026
Closed $6.03 (-3.8%) on Nov 13, 2026
CapsoVision to Release Third Quarter 2026 Financial Results on November 12, 2026
Oct 29, 2026
Closed $6.83 (-1.6%) on Oct 30, 2026
CapsoVision to Present at the 20th Annual LD Micro Main Event
Oct 13, 2026
Closed $6.64 (-2.1%) on Oct 14, 2026
CapsoVision Announces FDA Clearance of AI Highlights for CapsoCam Plus(R)
Sep 29, 2026
Closed $6.69 (-3.3%) on Sep 29, 2026
CapsoVision Announces FDA Clearance of AI Highlights for CapsoCam Plus®
Sep 28, 2026
Closed $6.92 (+4.1%) on Sep 28, 2026
CapsoVision to Participate in Upcoming Investor Conferences
Sep 3, 2026
Closed $5.99 (+0.3%) on Sep 4, 2026
CapsoVision Reports Second Quarter 2026 Financial Results
Aug 13, 2026
Closed $6.46 (-4.9%) on Aug 14, 2026
CapsoVision® Announces International Launch of AI Highlights
Aug 3, 2026
Closed $6.94 (-3.2%) on Aug 4, 2026
CapsoVision to Release Second Quarter 2026 Financial Results on August 13, 2026
Jul 30, 2026
Closed $6.58 (-1.8%) on Jul 31, 2026
CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors
Jul 2, 2026
Closed $6.61 (-9.2%) on Jul 6, 2026
CapsoVision, Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 17 in the last 12 months · 27 in all · newest Nov 12, 2026 · oldest 2025
- Calls
- 6 calls with a replay · 6 with a transcript · latest Nov 12, 2026
- Decks
- 2 decks · latest August 2026
Where CapsoVision, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CV · Home listing · This page | NASDAQ | United States | USD |
| Frankfurt:H6U | Frankfurt | Germany | EUR |
| BOATS:CV | BOATS | United States | USD |
| Munich:H6U | Munich | Germany | EUR |
| Dusseldorf:H6U | Dusseldorf | Germany | EUR |
Valuation
EV/sales 21.9× against a median of 3.2×: 10th lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $304.1M USD
- P/E
- Loss
- EV/sales
- 21.9×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 12.3×
- Gross margin
- 49.7%
- Operating margin
- −212.1%
- Net margin
- −210.1%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 0.88
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| CapsoVision, Inc. · NASDAQ:CV | US$325.1M | US$304.1M | n/a | 21.9× | n/a | 12.3× | −210.1% | 0.0× | 0.88 |
| Star Sports Medicine Co., Ltd Class H · HKEX:1609 | US$347.2M | US$183.4M | 16.9× | 3.0× | 6.8× | 1.8× | 34.0% | 0.0× | n/a |
| Embecta Corp. · NASDAQ:EMBC | US$341.1M | US$1.58B | 3.9× | 1.6× | n/a | n/a | 8.6% | n/a | 0.74 |
| COLTENE Holding AG · SIX:CLTN | US$336.6M | US$376.3M | 18.9× | 1.3× | 11.4× | 3.0× | 6.2% | 0.6× | n/a |
| Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A · SZSE:301290 | US$330.8M | US$220.5M | 29.6× | 3.4× | n/a | 1.0× | 17.2% | 0.1× | n/a |
| ACRO Biomedical Co., Ltd. · TPEX:6748 | US$327.3M | US$299.5M | n/a | 258× | n/a | 10.1× | −216.1% | 0.0× | n/a |
| Medcaptain Medical Technology Co. Ltd. Class H · HKEX:2041 | US$325.9M | US$288.8M | 44.4× | 1.2× | 9.7× | 1.1× | 3.0% | 0.1× | n/a |
| Yantai Zhenghai Bio-Tech Co. Ltd. Class A · SZSE:300653 | US$325.8M | US$231.2M | 34.2× | 4.8× | n/a | 2.4× | 19.9% | 0.0× | n/a |
| NIOX Group PLC · LSE:NIOX | US$318.1M | US$297.0M | 34.7× | 4.7× | 15.3× | 3.7× | 14.4% | 0.0× | n/a |
| Nanjing Medlander Medical Technology Co. Ltd. Class A · SSE:688273 | US$315.5M | US$208.7M | 33.0× | 3.6× | n/a | 1.5× | 16.6% | 0.0× | n/a |
| Supermax Corp. Bhd. · MYX:SUPERMX | US$312.4M | US$215.6M | n/a | 1.2× | n/a | 0.3× | −20.9% | 0.1× | n/a |
| Median of the others | US$326.6M | US$260.0M | 31.3× | 3.2× | 10.6× | 1.8× | 11.5% | 0.0× | 0.74 |
Forecasts
2 strong buy · Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.
- Price target
- 9.50 USD · Analysts' mean
- EPS, year to Dec 2026
- -0.56 · 2 analysts
- Revenue, year to Dec 2026
- 14.6M · 2 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Kang-Huai Wang | Co-Founder, President and Chief Executive Officer |
Board
| Director | Role |
|---|---|
| Chen Lung Tsai | Chairman of the Board |
| David S. Shields | Director |
| Hui Ying Kuo | Director |
| Julia Gouw | Director |
| Kang-Huai Wang | Co-Founder, President and Chief Executive Officer |
| Michele Harari | Director |
| Wen-Herng Henry King | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| CapsoVision (NASDAQ:CV) Q3 2026 Earnings Call | Thu, Nov 12, 2026 · 4:30 PM ET | Replay |
| CapsoVision (NASDAQ:CV) Q2 2026 Earnings Call | Thu, Aug 13, 2026 · 4:30 PM ET | Replay |
| CapsoVision (NASDAQ:CV) Q1 2026 Earnings Call | Thu, May 14, 2026 · 4:30 PM ET | Replay |
| CapsoVision (NASDAQ:CV) Q4 2025 Earnings Call | Thu, Mar 26, 2026 · 4:30 PM ET | Replay |
| CapsoVision (NASDAQ:CV) Q3 2025 Earnings Call | Thu, Nov 13, 2025 · 4:30 PM ET | Replay |
| CapsoVision (NASDAQ:CV) Q2 2025 Earnings Call | Thu, Aug 14, 2025 · 4:30 PM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 12, 2026 · After close | −3.8% |
| Q2 2026 | Aug 13, 2026 · After close | −4.9% |
| Q1 2026 | May 14, 2026 · After close | −11.6% |
| Q4 2025 | Mar 26, 2026 · After close | −0.3% |
| Q3 2025 | Nov 13, 2025 · After close | −9.7% |
| Q2 2025 | Aug 14, 2025 · After close | −4.2% |
| Q1 2025 | May 28, 2025 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (August 2026) | Investor deck | 20 slides | August 2026 |
| IPO Roadshow (June 2025) | IPO roadshow | 21 slides | Jun 2, 2025 |
Financings
| Raise | Date |
|---|---|
| At-the-market programme of common stock Announced: up to US$100M · Cantor Dealers: Cantor (lead) | Aug 13, 2026 |
| Public offering of common stock Closed: US$27.5M raised · US$5 a share · The Benchmark Company, LLC +1 Dealers: The Benchmark Company, LLC (co-lead), Roth Capital Partners (co-lead) | Jul 3, 2025 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Priced at US$5.00 a share on Jul 2, 2025.
- Price
- US$5.00 a share
- Shares offered
- 5,500,000 shares of common stock
- Offering size
- US$27.5 million
- Underwriters' option
- Up to 825,000 more shares
- Underwriters
- The Benchmark Company, Roth Capital Partners · In the order on the cover
- Shares delivered
- On or about Jul 3, 2025
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Feb 7, 2025 |
| Filed publicly | May 9, 2025 |
| Amended 3 times | Newest Jun 27, 2025 |
| Shares registered with an exchange | Jun 13, 2025 |
| Declared effective by the SEC | Jul 1, 2025 |
| Final prospectus, with the price | Jul 3, 2025 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jul 3, 2025 |
| CERT · Exchange's certificate of listing | Jul 2, 2025 |
| EFFECT · Notice that a registration is effective | Jul 1, 2025 |
| CORRESP · Letter to the SEC | Jun 30, 2025 |
| CORRESP · Letter to the SEC | Jun 30, 2025 |
| S-1/A · Registration statement, amended | Jun 27, 2025 |
| 8-A12B · Registration of shares for listing on an exchange | Jun 13, 2025 |
| S-1/A · Registration statement, amended | Jun 13, 2025 |
| FWP · Free writing prospectus | Jun 2, 2025 |
| S-1/A · Registration statement, amended | May 30, 2025 |
All 18 filings
| Filing | Filed |
|---|---|
| CORRESP · Letter to the SEC | May 9, 2025 |
| S-1 · Registration statement | May 9, 2025 |
| UPLOAD · Letter from the SEC | Mar 28, 2025 |
| DRSLTR · Letter to the SEC with a draft | Mar 14, 2025 |
| DRS/A · Draft registration statement, amended | Mar 14, 2025 |
| UPLOAD · Letter from the SEC | Mar 10, 2025 |
| DRSLTR · Letter to the SEC with a draft | Feb 7, 2025 |
| DRS · Draft registration statement | Feb 7, 2025 |
Open IPO · From the cover of the final prospectus (424B4) filed Jul 3, 2025
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 13.6M | 11.8M | 9.75M |
| Cost of revenue | 6.38M | 5.38M | 4.26M |
| Gross profit | 7.17M | 6.38M | 5.49M |
| Research and development | 18.3M | 15.1M | 9.33M |
| Selling, general and administrative | 6.85M | 4.21M | 1.97M |
| Operating income | -25.5M | -19.9M | -11.3M |
| Depreciation and amortization | 216.0K | 206.0K | 388.0K |
| EBITDA | -25.3M | -19.7M | -11.0M |
| Income before tax | -25.3M | -19.9M | -11.3M |
| Income tax | 24.0K | 11.0K | 11.0K |
| Net income | -25.3M | -19.9M | -11.3M |
| Earnings per share, basic | -1.03 | -9.85 | -0.29 |
| Earnings per share, diluted | -1.03 | -9.85 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cash and equivalents | 10.1M | 9.32M | 14.6M |
| Receivables | 2.50M | 2.00M | 1.87M |
| Inventory | 2.99M | 2.63M | 2.19M |
| Current assets | 16.7M | 14.8M | 19.2M |
| Property, plant and equipment | 611.0K | 720.0K | |
| Total assets | 18.2M | 16.8M | 21.5M |
| Accounts payable | 1.14M | 749.0K | 361.0K |
| Current liabilities | 4.43M | 1.80M | 1.51M |
| Total debt | 887.0K | 1.24M | 1.51M |
| Total liabilities | 4.90M | 2.69M | 131.4M |
| Shareholders' equity | 13.3M | -129.5M | -109.8M |
| Shares outstanding | 46.9M | 2.09M | 38.6M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cash from operations | -22.9M | -20.1M | -10.8M |
| Capital spending | -90.0K | -153.0K | -754.0K |
| Free cash flow | -23.0M | -20.2M | -11.6M |
| Cash from investing | -90.0K | -153.0K | -754.0K |
| Cash from financing | 23.6M | 15.1M | 20.5M |
| Change in cash | 650.0K | -5.17M | 9.01M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-Q · Quarterly report | Nov 12, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 12, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 4, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Sep 28, 2026 | Current report | SEC |
| 4 · Change in ownership | Sep 23, 2026 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Sep 23, 2026 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Sep 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 18, 2026 | Insider trade | SEC |
| 8-K · Current report | Sep 18, 2026 | Material contract | SEC |
| 424B5 · Prospectus | Sep 18, 2026 | Offer document | SEC |
All 143 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| EFFECT · Notice that a registration is effective | Aug 24, 2026 | Other filings | SEC |
| 424B5 · Prospectus | Aug 21, 2026 | Offer document | SEC |
| 8-K · Current report | Aug 17, 2026 | Current report | SEC |
| S-3 · Registration statement | Aug 13, 2026 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 13, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 13, 2026 | Results | SEC |
| 4 · Change in ownership | Jul 21, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 7, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 2, 2026 | Insider trade | SEC |
| 8-K · Current report | Jul 2, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Jul 1, 2026 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jul 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2026 | Insider trade | SEC |
| 8-K · Current report | Jun 12, 2026 | Meeting outcome | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | May 14, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 14, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 6, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | May 6, 2026 | Insider trade | SEC |
| DEF 14A · Proxy statement | Apr 28, 2026 | Meeting notice | SEC |
| EFFECT · Notice that a registration is effective | Apr 23, 2026 | Other filings | SEC |
| 424B3 · Prospectus | Apr 22, 2026 | Offer document | SEC |
| CORRESP · Letter to the SEC | Apr 17, 2026 | Other filings | SEC |
| S-1 · Registration statement | Apr 17, 2026 | Offer document | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 15, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 7, 2026 | Big-stake notice | SEC |
| UPLOAD · Letter from the SEC | Apr 7, 2026 | Other filings | SEC |
| DRS · Draft registration statement | Apr 3, 2026 | Offer document | SEC |
| 3 · Initial statement of ownership | Mar 30, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 26, 2026 | Insider trade | SEC |
| 10-K · Annual report | Mar 26, 2026 | Annual report | SEC |
| 8-K · Current report | Mar 26, 2026 | Results | SEC |
| 4 · Change in ownership | Mar 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 23, 2026 | Insider trade | SEC |
| 8-K · Current report | Mar 20, 2026 | Results | SEC |
| 8-K · Current report | Mar 13, 2026 | Material contract | SEC |
| 4/A · Change in ownership, amended | Feb 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Dec 31, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 31, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 31, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 31, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 31, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 31, 2025 | Insider trade | SEC |
| 8-K · Current report | Dec 29, 2025 | Current report | SEC |
| SCHEDULE 13G · Big-stake notice | Dec 22, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 13, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 13, 2025 | Results | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 12, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Nov 10, 2025 | Current report | SEC |
| 4 · Change in ownership | Nov 3, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Nov 3, 2025 | Insider trade | SEC |
| 8-K · Current report | Nov 3, 2025 | Management or board change | SEC |
| SCHEDULE 13G · Big-stake notice | Oct 29, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Oct 14, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Sep 26, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Sep 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 17, 2025 | Insider trade | SEC |
| 8-K · Current report | Sep 3, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Aug 22, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 14, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 14, 2025 | Results | SEC |
| 8-K · Current report | Jul 18, 2025 | Material contract | SEC |
| S-8 · Registration statement for employee plans | Jul 10, 2025 | Offer document | SEC |
| 4/A · Change in ownership, amended | Jul 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 7, 2025 | Insider trade | SEC |
| 8-K · Current report | Jul 3, 2025 | Material contract | SEC |
| 424B4 · Prospectus | Jul 2, 2025 | Offer document | SEC |
| 3 · Initial statement of ownership | Jul 2, 2025 | Insider trade | SEC |
| CERT · Exchange's certificate of listing | Jul 2, 2025 | Other filings | SEC |
| EFFECT · Notice that a registration is effective | Jul 2, 2025 | Other filings | SEC |
| 3 · Initial statement of ownership | Jul 1, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 1, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 1, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 1, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 1, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 1, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 1, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 1, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 1, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 1, 2025 | Insider trade | SEC |
| CORRESP · Letter to the SEC | Jun 30, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jun 30, 2025 | Other filings | SEC |
| S-1/A · Registration statement, amended | Jun 26, 2025 | Offer document | SEC |
| 8-A12B · Registration of shares for listing on an exchange | Jun 13, 2025 | Other filings | SEC |
| S-1/A · Registration statement, amended | Jun 13, 2025 | Offer document | SEC |
| FWP · Free writing prospectus | May 30, 2025 | Offer document | SEC |
| S-1/A · Registration statement, amended | May 30, 2025 | Offer document | SEC |
| CORRESP · Letter to the SEC | May 9, 2025 | Other filings | SEC |
| S-1 · Registration statement | May 9, 2025 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Mar 28, 2025 | Other filings | SEC |
| DRSLTR · Letter to the SEC with a draft | Mar 14, 2025 | Other filings | SEC |
| DRS/A · Draft registration statement, amended | Mar 14, 2025 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Mar 10, 2025 | Other filings | SEC |
| DRSLTR · Letter to the SEC with a draft | Feb 7, 2025 | Other filings | SEC |
| DRS · Draft registration statement | Feb 7, 2025 | Offer document | SEC |
| D/A | Jul 22, 2024 | Other filings | SEC |
| D/A | Oct 18, 2023 | Other filings | SEC |
| D/A | Mar 6, 2023 | Other filings | SEC |
| D/A | Mar 10, 2021 | Other filings | SEC |
| D | Jun 17, 2020 | Other filings | SEC |
| D | Nov 26, 2019 | Other filings | SEC |
| D | Oct 30, 2018 | Other filings | SEC |
| D | Oct 30, 2018 | Other filings | SEC |
| D | Apr 22, 2016 | Other filings | SEC |
| D | Feb 20, 2014 | Other filings | SEC |
| D | Oct 26, 2012 | Other filings | SEC |
| D | Sep 5, 2012 | Other filings | SEC |
| D | Jun 28, 2012 | Other filings | SEC |
| D | Dec 22, 2011 | Other filings | SEC |
| D | Feb 7, 2011 | Other filings | SEC |
| D | Feb 25, 2010 | Other filings | SEC |
| D | Aug 5, 2009 | Other filings | SEC |
| REGDEX | Oct 17, 2006 | Other filings | SEC |
Cap table
Built by 6ix from CapsoVision, Inc.’s releases · as of Sep 30, 2026
- Common shares
- 53,210,357
- Fully diluted
- 53,210,357
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 53,210,357 | Sep 30, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 53,210,357 |
| Sep 30, 2026 | 53,569,896 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Julia Gouw Other companies: Vizio Holding Corp (Director · Mar 24, 2021 – Dec 3, 2024 · Past) | Director · Since at least Jul 1, 2025 |
| Kevin Lundquist Other companies: Outlook Therapeutics, Inc. (Chief Financial Officer · Since at least Sep 1, 2026) | Chief Financial Officer · Since at least Jul 1, 2025 |
| Chen Lung Tsai | Chairman of the Board · Since at least Jul 1, 2025 |
| David Garcia | Sr. VP of Finance · Since at least Nov 3, 2025 |
| David S. Shields | Director · Since at least Jul 1, 2026 |
| Douglas Patrick Atkinson | Head of Global Sales · Since at least Jul 1, 2025 |
| Hui Ying Kuo | Director · Since at least Jul 1, 2025 |
| Joanne Carol Imperial | Director · Since at least Jul 1, 2025 |
| Kang-Huai Wang | Co-Founder, President and Chief Executive Officer · Since at least Jul 1, 2025 |
| Michele Harari | Director · Since at least Jul 1, 2025 |
All 12 people
| Person | Seat |
|---|---|
| Rebecca Ann Petersen | Director of Clinical Affairs · Since at least Jul 1, 2025 |
| Wen-Herng Henry King | Director · Since at least Jun 30, 2026 |
Log in to ask 6ix AI your own questions about CapsoVision, Inc.